Phase 3 Hyperlipidemia Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Hyperlipidemia
Merck Sharp & Dohme LLC975 enrolled89 locationsNCT07216482
Recruiting
Phase 3
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.760 enrolled2 locationsNCT07421297
Recruiting
Phase 3
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Hyperlipidemia
Beijing Suncadia Pharmaceuticals Co., Ltd900 enrolled1 locationNCT07230730
Recruiting
Phase 3
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
Primary Hyperlipidemia
Gan & Lee Pharmaceuticals.240 enrolled1 locationNCT06780410
Not Yet Recruiting
Phase 3Phase 4
Nicotinic Acid and Lipoprotein (a): The Effect of Extended Release Nicotinic Acid on Plasma Lipoprotein (a), its Isoforms and apo(a) Fragments
Hyperlipidemia
A/Prof. K.Kostner30 enrolled1 locationACTRN12611000252910